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Abstract.  Thin, frozen sections of a HeLa cell line 
were double labeled with specific  antibodies to local- 
ize the trans-Golgi enzyme,/31,4 gaiactosyltransferase 
(GaiT) and the medial enzyme, N-acetylglucosaminyl- 
ransferase I (NAGT I). The latter was detected by 
generating a HeLa cell line stably expressing a myc- 
tagged version of the endogenous protein. GAIT was 
found in the trans-cisterna and trans-Golgi network 
but, contrary to expectation, NAGT I was found both 
in the medial- and trans-cisternae, overlapping the dis- 
tribution of GAIT. About one third of the NAGT I and 
half of the GaIT were found in the shared, trans- 
cisterna. These data show that the differences between 
cisternae are determined not by different sets of en- 
zymes but by different mixtures. 
T 
HE construction  of N-linked,  bi-antennary  oligosac- 
charides in the Golgi apparatus is a three-stage process. 
The first stage, thought to take place in the cis-Golgi 
network  (CGN)l/cis-cisternae,  continues  the trimming  of 
mannose residues  started  in the ER.  The second stage, in 
medial-cisternae,  involves addition of  N-acetylglucosamine, 
the removal of a further two mannose residues and the addi- 
tion of another N-acetylglucosamine.  Fucose may also be 
added at this stage. The third and last stage, in the trans- 
cisternae and trans-Golgi network (TGN), involves addition 
of galactose followed by sialic acid (for review see Kornfeld 
and Kornfeld,  1985). 
These activities have been assigned to the different cister- 
nae and networks based on localiTation  of  the appropriate en- 
zymes and their products (for reviews see Dunphy and Roth- 
man,  1985, and  Roth,  1987). The  first  stage  enzyme, 
mannosidase I, is thought to reside in the CGN/cis-cister- 
nae because it acts on oligosaccharides attached to proteins 
that have just left the ER (Balch et al.,  1986) and before 
the second stage enzyme, N-acetylglucosaminyltransferase I 
(NAGT  I),  which  has  been  immunolocalized  to medial- 
cisternae  (Dunphy et al.,  1985). Other second  stage  en- 
zymes (mannosidase  II and NAGT H)  cofractionate  with 
NAGT I on sucrose gradients and, since they can be partially 
separated  from third-stage  enzymes  (/31,4 galactosyltrans- 
ferase  [GAIT] and ot2,6 sialyltransferase  [SialylT]) on the 
same gradients (Dunphy et al., 1981; Dunphy and Rothman, 
Tommy Nilsson and Marc Pypaert  contributed  equally to this work. 
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1983; Goldberg and Kornfeld, 1983) they are assumed to oc- 
cupy the medial-cisternae.  The third stage  enzymes have 
been immunolocalized to the trans-cisternae and TGN (Roth 
and Berger, 1982; Strous et al., 1983; Slot and Geuze, 1983; 
Roth et al.,  1985) and though these membranes  have not 
been cleanly separated either biochemically or cytochemi- 
cally, there  is  data suggesting that SialylT,  unlike  GaiT, 
might be concentrated  more in the TGN than the  trans- 
cisternae (Roth et al.,  1985). 
These data have led to the view that enzymes involved in 
the three stages of construction are physically separated in 
cisternae that are ordered in a stack. There have been occa- 
sional reports of Golgi residents occupying more than one 
group of cisternae (Novikoff et al., 1983; Roth et al., 1986; 
Hendricks  et al.,  1991) but they have generally  been  re- 
garded as exceptions to the rule. 
Despite the wide acceptance of this model there is no di- 
rect evidence in support of  it. The most compelling evidence 
would come from immunolabeling studies, showing that the 
enzymes of each stage are physically restricted to cisternae 
distinct from the others. The main barrier to such an analysis 
has been the lack of  antibodies that recognize enzymes in the 
different stages within the same species. The problem has 
been compounded by the unresolved difficulty of producing 
antibodies useful for quantitative immuno-electron  micro- 
scopic studies. 
We have overcome this problem  by generating a stable 
HeLa cell line expressing a medial-Golgi enzyme, NAGT I, 
tagged with a myc epitope, which is recognized by the high 
affinity mAb, 9El0. This has been used, in double-label ex- 
periments,  with polyclonal antibodies to a trans-Golgi  en- 
zyme, GaiT. The results show that the distributions are not 
discrete but overlap substantially. 
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Recombinant DNA 
The human NAGT I eDNA (Kumar et al.,  1990),  inserted into pGEM 
(Promega Corp., Madison, WI), was used as a template in a polymerase 
chain reaction (PCR) (Saiki et al.,  1988).  PCR primers were as follows 
(bases encoding the myc epitope recognized by the 9El0 mAb [Evan et al., 
1985] are underlined): 
5'GGATCCGGATCCTCTAGACCATGATCAAGAAGCAGTCTGCTGGCCTGGTG 
5~GATCCGGATCCTTACAGGTCTTCTTCAGAGATCAGTTTCTGTTCCGGATT 
CCAGCTAGGATCATAGCCCTC 
To introduce a Kozak consensus sequence (see Kozak, 1983) for proper ini- 
tiation of translation, the first codon after the ATG was changed from CTG 
(encoding leucine) to ATC (encoding isoleucine). The PCR product was next 
digested with BamHI and cloned into pCMUIV (Nilsson et al., 1989). After 
sequencing and transient expression, the m~NAGT I eDNA was transferred 
into pSRc~ (DNAX, Palo Alto, CA) for stable integration into Hela ceils. 
Cell Culture and Transfection 
Monolayer HeLa cells (ATCC CCL185) were grown in DME (Northumbria 
Biologicals Limited, Cramiington, UK) supplemented with 10% FCS, pen- 
icillin, and streptomycin at 100/~g/mi.  After transfection with the cDNA 
encoding mycNAGT I (Nilsson et al.,  1989), ceils were maintained in the 
above medium containing 450 ~g/mi Geneticin (G-418  sulphate)  (Gibco 
Laboratories,  Inc., Grand Island, NY) for 3 wk before isolation of individual 
clones. Clones were screened by indirect immunofluorescence using the 9El0 
mAb (see below) and diluted to single cells for a second round of cloning. 
The mycNAGT I HeLa cells were maintained in the presence of 200/~g/mi 
Geneticin. 
Preparation of Golgi Membranes 
Golgi membranes were prepared from the parental and stable cell lines as 
described by Balch et al. (1984) using ,~109 cells.  Harvested Golgi mem- 
branes were purified 25-30-fold over the crude homogenate (as assayed for 
by GaIT activity). Protein was assayed using the BCA protein assay kit (Pierce 
Chemical Co., Rockford,  IL). 
Assays for GaiT and NAGT I 
GaIT (E.C.2.4.1.22)  was assayed as described by Bretz and St~ubli (1977) 
and NAGT I (E.C.2.4.1.101) as described by Visiter and Hughes (1981) ex- 
cept that reactions were incubated for 2.5 h, stopped with ice-cold 1% phos- 
phomngstic acid/0.5  M HCI,  the precipitates washed once with the same 
mixture and once with ice-cold 95 % EtOH. The pellets were soinbilized 
in 0.4 M unbuffered Tris/4%  SDS for 1-2 h before the addition of scintilla- 
tion fluid. 
Western Blotting 
After SDS-PAGE, proteins were transferred onto Hybond-C super membranes 
(Amersham Corp., Arlington Heights,  IL) using a semi-dry blotter. Filters 
were next blocked overnight using 5% nonfat milk and 0.2% Tween-20 in 
PBS. First antibodies were used at a dilution of 1:1,000 followed by second- 
ary antibodies conjugated to peroxidase (3~go, Inc., Burlingame,  CA). The 
bands were visualized using the ECL detection reagents (Amersham Corp.). 
Indirect Immunofluorescence and 
Confocal Microscopy 
The stable cell line was processed for indirect immunofluorescence  (Lou- 
yard et al., 1982; Warren et al., 1984) using 0.2% fish skin gelatin instead 
of bovine  gelatin to minimize nonspecific binding. Secondary antibodies con- 
jugated to Texas red (Vector Laboratories, Inc., Burlingame,  CA) or FITC 
(DAKOPATIS, Copenhagen) were used to visualize the primary antibodies. 
Both primary and secondary antibodies were preadsorbed onto cells fixed 
with paraformaldehyde  and permeabilized with Triton X-100 before stain- 
ing. Cells were visualized using a Bio-Rad MRC-600 Laser scanning confo- 
cal Imaging system (Bio-Rad Laboratories, Richmond, CA). Bleed-through 
from the fluorescein channel into the Texas red channel amounted to 10% 
and was corrected for in the images scanned. Final images were merged using 
Photoshop on a Macintosh computer and photographed directly from the 
scr~n. 
Immunoelectron Microscopy 
Monolayer HeLa cells were fixed for 1 h at room temperature (RT) with 
0.5%  (vol/vol) glntaraldehyde  (Fluka BioChemika, Glossop,  England)  in 
0.2 M Pipes buffer, pH 7.2.  They were washed twice in the same buffer, 
scraped from the dish and spun at 13,000 g for 10 rain at RT. The pellets 
were infiltrated with a solution of 2.1 M sucrose in PBS, pH 7.4, for 30 win 
at RT, then mounted onto aluminium studs and quickly  frozen in liquid 
nitrogen. 
100-rim-thick sections were cut at -90~  using an ullracut E microtome 
with FC4E cryoattachment,  and then transferred onto formvar- and carbon- 
coated 100-mesh grids. Before immunolabeling, free aldehyde groups were 
quenched by incubation for 10 win at RT with 0.1 M ammonium chloride 
in PBS. The sections were washed for 5 min with 0.5% fish skin gelatin in 
PBS (PBS/gelatin),  pH 7.4, then incubated in 8/~1 of antibody (rabbit anti- 
GAIT) diluted in PBS/gelatin  in a moist chamber for 30 min at RT. After 
six washes in PBS/gelatin  (15 win total), the grids were incubated for 20 
rain at RT in 8 ~1 of goat anti-rabbit IgG conjugated  to 5- or 10-nm gold 
particles (Bioceli  Research  Laboratories, Cardiff,  UK) diluted 20-fold in 
PBS-gelatin. The grids were finally washed six times in PBS (30 rain total). 
FOr the double-labeling experiments, the grids were first incubated in a mix- 
ture of anti-GaiT and anti-myc (gEl0) antibodies followed by goat anti- 
mouse IgG-gold and then the anti-rabbit IgG-gold with appropriate washes 
in between. 
Sections were contrasted and embedded in epoxy resin using a modifica- 
tion of the method of Keller et al. (1984), essentially as described by Lucocq 
et al. (1989). They were stained for 10 win with lead citrate according to 
the method of Reynolds (1963), and then examined at 80 kV in a Phillips 
CM10 electron microscope (Phillips  Scientific,  Mahwah,  NJ). 
Immunogold Quantitation 
Golgi profiles were sampled at random, photographed, and printed at a final 
magnification  of 98,000.  Only those profiles which were sectioned  trans- 
versely and showed polarized labeling with anti-GaiT were selected  for 
quantitation. For the double-labeling experiments,  another condition was 
that the profiles  selected  were labeled with at least one gold particle of 
each size. 
Cisternae were assigned as described in the text and the density of gold 
in each cisterna was calculated by counting the number of gold particles and 
dividing it by the surface area of the cisternal profile expressed in/tm  2. The 
latter was measured using a square lattice grid with 5-ram point-point spac- 
ing.  The surface  area of a cisternal profile  ffi EP  ￿  d 2 where ~:P is the 
number of points falling over it and d is the distance between lines of the 
grid. When a gold particle was found between two cisternae,  it was assigned 
to the one which was the closest.  The same principle was used to assign 
points from the grid which fell over the intracisternal space.  Background 
was calculated by counting the number of gold particles over large areas of 
cytoplasm, and dividing this number  by the surface estimated using a square 
lattice grid with 20-ram spacing.  The significance  of the labeling density 
was assessed  using the t test and a probability level of 0.05. 
Linear densities were estimated by dividing the number of gold particles 
by the length of cisternal membrane measured by counting intersections  of 
membrane with lines of a grid with a  10-mm point-point spacing. 
During the course of these experiments,  a different batch of anti-rabbit 
IgG-gold complex was used which nearly doubled the level of signal and 
background. To compare data using these different antibodies,  a correction 
factor  was  applied  which  was  calculated  using  a  simple test system. 
Formvar- and carbon-coated grids were floated on PBS/gelatin for 5 win, 
then incubated with 8/d of anti-GaiT antibodies as described above. After 
six short washes in PBS/gelatin (5 min total), the grids were labeled for 20 
rain with either batch of anti-rabbit IgG-gold complex diluted 20-fold in 
PBS/gelatin. The grids were washed six times in PBS (5 win total), air dried 
after a short wash in distilled water, and the gold particles then counted at 
the electron microscope.  The new batch of gold complex gave, on average, 
1.67 times more gold particles than the older batch, and this value was used 
to correct the data. 
Stereology 
Cells were sampled at random, then photographed, and the pictures printed 
at a final magnification of 16,000. Golgi stacks within these cells were sam- 
pied, photographed, and the pictures printed at a final magnification  of 
90,000. 
Surface  densities of Golgi membrane per unit volume of cytoplasm 
(Sgo/Vcyto) and mitochondria (Sgo/Vr~to) were calculated using the follow- 
ing equations: 
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Sso/V~o = SjVso x  vs./V~,o  (2)  ~ 
where Sgo/Vgo is the surface density of Golgi membrane within individual 
Golgi stacks, Vgo/V~o is the fraction of cytoplasmic volume occupied by 
Golgi stacks, and Vgo/Vmito is the ratio of the volume of Golgi stacks per 
volume of mitochondria.  "~ 
Sso/Vgo was estimated from the higher magnification (90,000) pictures  0 
using a square lattice grid with 20-mm spacings. The equation r~I/~:P x  d  ~ 
gave Sgo/Vgo, where r.I is the sum of vertical and horizontal intercepts of 
the lattice grid with Golgi membranes, r~p is the sum of the points falling 
over Golgi cisternae or associated vesicles as well as over the intracisterual  ,~ 
space,  and d  is the distance between lines of the grid.  "~ 
Vgo/V~to  and Vgo/V~ato were  estimated  from the lower magnification 
(16,000) pictures using the same lattice grid as above, by counting the num- 
ber of points falling over Golgi areas and dividing it by the number of points  O  falling over the cytoplasm or mitochondria,  f,~ 
Results 
Distribution of GaiT by lmmuno-EM 
Thin, frozen sections of the parental HeLa cell line were la- 
beled with polyclonal antibodies specific for the polypeptide 
chain of GalT (Watzele et al.,  1991),  followed by anti-rabbit 
IgG coupled to 10 nm gold. The specificity of the antibody 
was confirmed by showing that the signal over the Golgi was 
37 times that over the cytoplasm. 
GaIT was found in two cisternae on one side of the stack 
(Fig. 1) in agreement with earlier results on the same cell line 
(Roth and Berger,  1982; Lucocq et al.,  1989).  To provide a 
consistent framework for quantitation, the trans-cisterna  (T) 
was defined as the last continuous cisterna labeled by anti- 
bodies to GaIT (see Fig.  1). The high level of labeling meant 
that most transversely sectioned Golgi stacks were counted. 
The medial-cisterna would be T-1 and the cis-cisterna T-2. 
The next cisterna,  T-3, could represent the CGN but this 
was only present in 30-50 % of the sections depending on the 
experiment. The tubulo-vesicular cisterna on the other side 
of the T cisterna, T+I, most probably represented the TGN. 
Labeling  for  GaIT  was  quantified  and  the  results  are 
presented as the number of gold particles per #m  2 of cister- 
nal profile (Fig. 2).  Labeling was almost entirely restricted 
200" 
100' 
T+I  T  T-1  T-2  T-3 
Cisterna 
Figure 2.  Quantitative  distribution  of GalT. Images such as that 
presented in Fig. 1 were used to calculate the density of gold par'ti- 
des over each cisternal profile. Results are presented as the mean 
5: SEM (n =  10). Background labeling was 2.6 gold particles per 
t~m  2 of cytoplasm. 
to the T and T+I cisternae. Labeling of the other cisternae 
was not significantly above background with the exception of 
the T-1 cisterna though this was not a consistent observation 
(see below). Differences were considered significant at the 
p  <  0.05 level using the t test. This level of significance was 
used in all subsequent experiments. 
Characterization of a Stable Cell Line 
Expressing mycNAGT I 
The localization of NAGT I was made possible by generating 
a  HeLa cell line stably expressing human NAGT I  tagged 
with a myc epitope. This was placed at the extreme COOH 
terminus of the protein, which resides in the Golgi lumen. 
The mycNAGT  I eDNA (Kumar et al., 1990) was transferred 
into pSRa (see Materials and Methods) and stable transfor- 
mants were selected in the presence of geneticin. The clone 
Figure 1. Distribution of GaIT 
by immuno-EM. Thin, frozen 
sections of  parental HeLa cells 
were labeled  with  polyclonal 
anti-GaiT  followed  by  anti- 
rabbit IgG coupled to 10 nm 
gold.  The T cisterna  (see in- 
set)  was  defined  as  the  last 
continuous  cisterna  that  la- 
beled for GAIT.  The others are 
indicated  and  most probably 
represent the TGN (T+I), the 
medial-cisterna  (T-l),  and 
the cis-cistema (T-2).  Note 
that labeling for GaiT was re- 
stricted to the T and T+I cis- 
ternae.  Bar, 0.2 #m. 
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I in isolated Golgi membranes. 
Golgi  membranes  were  iso- 
lated  from both the  parental 
(Pa) and stable (St) cell lines, 
fractionated  by  SDS-PAGE, 
blotted, and probed with anti- 
bodies to either GaIT or myc- 
NAGT I. 
selected for this work expressed mycNAGT I in every cell at 
approximately equivalent levels, allowing for the phase of  the 
cell  cycle.  This  was assessed by  indirect  immunofluores- 
cence microscopy. 
The mycNAGT I had the expected molecular weight of 
55,000 (Fig. 3) and was enzymaticaily active as shown by the 
fourfold higher activity of isolated Golgi membranes when 
compared with those from the parental cell line  (Fig.  4). 
GaiT was used as an internal control in these experiments to 
correct for differences in the purity of the Golgi membranes. 
This was a valid control since the specific activity of GaiT 
was almost the same in the two cell lines (see legend to Fig. 
4) as was the amount of protein (Fig. 3). Enzyme activity was 
o 
v 
F~ 
L~ 
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Figure 4. Activity of NAGT I in the parental and stable cell lines. 
Isolated Golgi membranes were assayed for NAGT I activity. The 
results are expressed relative to the activity of GAIT, which had al- 
roost the same specific activity in both the parental (o) (43 nmoles/ 
h/mg protein) and stable (,) (51 nmoles/h/mg protein) cell lines 
so could be used to correct for differences in purity of the isolated 
membranes.  The results are the mean of two experiments and the 
ratio of the slopes is 4.1. 
Table L  The Volume and Surface Densities of Golgi in 
the Stable and Parental Cell Lines 
Cytoplasm  Mitochondria 
Cell Line  V,  S~ (~m  -~)  V,  S~ (pm-') 
Parental  0.054  + 0.024  1.68  + 0.76  0.40  + 0.21  12.5  :l: 6.8 
Stable  0.045 5:0.014  1.49  + 0.47  0.44 + 0.18  14.4  + 6.0 
The volume  density (V,) and surfi~c~  density (S~)  of the Golgi  for both  cell lines 
were estimated  relative  to either  cytoplasm  or mitochondria.  Results  are presantc~l 
as the mean + SEM (n = 8). The differences  between  the stable and paxcntal 
cell lines were not significant at the p  =  0.05  level using the t test. 
used to monitor the level of over-expression since estimates 
of the  protein level require  antibodies to the  endogenous 
NAGT I which are not yet available. The expression of myc- 
NAGT I  had no obvious effe~ on the morphology of the 
Golgi apparatus nor on its volume and surface area relative 
to either cytoplasm or mitochondria (Table I). 
Distribution of GaiT and mycNAGT I by Immuno-EM 
Thin, frozen sections of the stable cell line were labeled with 
a mixture of antibodies to localize both GaIT and mycNAGT 
I, followed by anti-rabbit and anti-mouse second antibodies 
coupled to different sizes of gold. The signal for mycNAGT 
I over the Golgi was 17 times that over the cell cytoplasm. 
This confirms the high specificity of the antibody suggested 
by Fig. 3. As shown in Fig. 5, A-C, mycNAGT I was mostly 
found in two cisternae,  T-1 and T. This was confirmed by 
quantitation  (Fig.  6  A) and showed that there was no sig- 
nificant difference in density over these two cisternae.  The 
density of labeling over the other cisternae was not signifi- 
cantly different from background. 
The density distribution of GaiT (Fig. 6 A) was very simi- 
lar to that seen in the parental cell line (Fig. 2) though the 
signal  over  the  Golgi  was  now  48  times  that  over  the 
cytoplasm and the density in all cisternae other than T  and 
T+I was not significantly above background. 
The  same distributions  were obtained when the  results 
were presented as linear densities (Fig.  6 B).  This format 
does not allow comparison with background labeling but is 
not distorted by differences in the volume of each cisterna. 
The distribution of GaiT clearly overlapped with that of 
mycNAGT I in the T  cisterna.  This overlap was not a rare 
event revealed only by collecting and summing the results 
from individual Golgi profiles. Fig. 5,  (A-C) shows typical 
examples of Golgi stacks used for counting purposes.  The 
high level of labeling with both antibodies clearly revealed 
double labeling of the T  cistema. In fact, of the 42 Golgi 
stacks used for counting, 36 showed double labeling of the 
T cisterna. Overlap was also observed when the sizes of the 
gold were reversed (Fig.  5, D  and E). 
The approximate amount of each enzyme in the shared, 
trans-cisterna was estimated by combining the density values 
with the estimated sizes of the cisternae. The T cistema con- 
tained 53 % of the GaiT and 35 % of the mycNAGT I. These 
figures assume that the labeling efficiency was the same for 
each cisterna. 
Distribution of  GaiT and mycNAGT I 
by Confocal Microscopy 
Given the precision with which these two enzymes could be 
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and mycNAGT  I by immuno- 
EM. Thin, frozen sections of 
the stable HeLa cell line were 
labeled with both polyclonal 
anti-GaiT and 9El0 antibod- 
ies  followed by  appropriate 
second antibodies coupled to 
different sizes of gold. (A-C) 
GaIT  =  10  nm gold,  myc- 
NAGT I  =  5  nm gold;  (D 
and E) GalT  =  5 nm gold, 
mycNAGT I  --  10 nm gold. 
Bars, 0.2 ~tm. 
localized by immuno-EM, it was of interest to determine 
their distribution by confocal microscopy. Work by Ram- 
bourg and Clermont 0990) suggests that the Golgi apparatus 
in three dimensions comprises a series of stacks linked by 
tubules to  form a  ribbon,  the tubules  linkins equivalent 
cistemae in adjacent stacks.  The cisternae themselves are in 
register, that is they sit one on top of the next in the stack. 
With this in mind, Fig. 7 shows a series of sections through 
the nuclear region of  the stable HeLa cell line labeled so as 
to reveal GalT in green (FITC) and mycN~3T I in red (Texas 
red).  The two columns on the left  show the unmerged pic- 
tures,  that on the right the merged ones. Overlap registers 
as yellow. 
There are three clear types of image in the merged pic- 
tures. The  first is  a  broad  area  of a  single color  which 
changes as one moves through the sections. The green area 
in Fig. 7 C (arma~ad) changes to red in Fig. 7 L (arrow- 
head) passing through intermediate~ of all three colors (Figs. 
7, F and/, arrowheads). This is most easily interpretexi as 
an en face section through the Golgi moving from the TGN 
(Fig. 7 C) through the tm~ (Fig. 7, F and l) to the medial 
(Fig. 7 L).  The OalT labeling appears stronger and more 
even than that of  the mycNAGT I but this may simply reflect 
the  differences  in  sensitivity  of  the  optical  system  rather  than 
a change to a more fenestrated structure. 
The second type of image is a  compact series of three 
colors with yellow in the middle (Fig. 7, I and L, arrows). 
The observed width and thickness is consistent with a trans- 
verse section  through a  stack.  The  third  and  last  type  shows 
the  same  distribution  of  the  three  colors  (Fig.  7 L, open ar- 
rowhead) but  they  are  more spread  out  suggesting  a  tangen- 
tial  section through a stack. 
As a positive control to show that the separation of labels 
was not an artefact of  the procedure or a limitation of  the ma- 
Nilsmn r  a. O~  ~  of ~o  ~  9 Figure 6.  Quantitative distribution of GaIT (.) and mycNAGT I 
([]). Images such as those presented in Fig. 5, A-C were used to 
calculate: (A) the density of  the two different sizes of gold over each 
cisternal profile. Results are presented as the mean number of gold 
particles per #m  2 +  SEM (n = 42). Background labeling was 1.9 
(GaiT) or 5.4 (mycNAGT I) gold particles//~m  2 of cytoplasm; (B) 
the linear density of  the two different sizes of  gold along each cister- 
ned membrane. Results are presented as the mean number of gold 
particles per #m length of membrane  +  SEM (n  =  42). 
chine, GaiT was double labeled using a monoclonal (Berger 
et al.,  1986) as well as the polyclonal antibody. The labels 
were superimposable (data not shown). 
Discussion 
The technical success of these double-label experiments re- 
lied on a stable HeLa cell line expressing NAGT I tagged 
with a myc epitope. The eDNA used encoded human NAGT I 
so there was no species incompatibility. The myc tag was 
placed at the extreme COOH terminus, well away from the 
retention signal at the other end of the protein (Tang et al., 
1992). The myc tag itself is only 11 amino acids in length, 
<2.5 % of the NAGT I protein, and has been used on many 
occasions with no discernible effect on the location of the 
protein (for example see Munro and Pelham, 1986). The tag 
had no apparent effect on the folding of the protein since a 
fourfold increase in activity was registered by enzyme assay. 
Enzymatic activity is probably the most sensitive measure of 
proper folding and lessens the possibility that the observed 
distribution is the consequence of a misfolded form of the 
protein. Endogenous NAGT I is a minor protein of the Golgi 
constituting <0.2%  of Golgi membrane protein in  rabbit 
liver (Nishikawa et al., 1988). A fourfold increase in amount 
would not then be expected to change the distribution of the 
protein  nor  the  structure  of  the  Golgi  and  in  fact  no 
significant changes in Golgi morphology, volume, or surface 
area were detected. There was also no change in the distribu- 
tion or amounts of the other Golgi enzyme, GAIT. Taken to- 
gether these data argue very strongly that the observed distri- 
bution of NAGT I  is not the consequence of expressing a 
myc-tagged version of the protein. 
An overlapping distribution of these two Golgi enzymes 
does not conflict with any of the published data.  Fraction- 
ation  experiments  showed that  the peak of GalT activity 
could be separated from NAGT I but the distributions on the 
gradient overlapped leaving open the possibility that they 
shared a cisterna. All immunocytochemical observations of 
medial- and trans-Golgi enzymes have been single-label ex- 
periments and their locations attributed using morphological 
criteria. The fact that different cell types from different spe- 
cies were used made it almost impossible to predict that 
overlap might have been present. 
In earlier experiments NAGT I was mostly found in two 
adjacent cisternae (Dunphy et al., 1985) suggesting duplica- 
tion of the cisterna containing the  second-stage oligosac- 
charide-modifying enzymes. The same was true for GaIT 
(Roth and Berger, 1982) suggesting duplication of the trans- 
cisterna each containing third stage enzymes. Our data argue 
strongly against cisternal duplication. Overlapping distribu- 
tions of these two enzymes generates three distinct cisternae 
not two sets of duplicate cisternae. This also means that each 
cisterna differs from its neighbors not by having completely 
different sets of enzymes but by having different mixtures. 
The large number of oligosaccharide-modifying enzymes in 
the Golgi could generate many mixtures, enough that even 
in those rare cases where the Golgi comprises stacks of a 
score or more cisternae (for example see Grass6 and Carasso, 
1957), each cisterna could have a different mixture and there- 
fore have a different set of functions. 
There has been a recent suggestion (Mellman and Simons, 
1992) that the cisternae in the stack are physically intercon- 
nected with each cisterna representing a domain within the 
overall structure. There is a precedent for such a structure 
in the ER which has both rough and smooth domains that are 
physically connected but these connections are frequently 
seen in marked contrast to those postulated for the Golgi 
stack.  Only  further  work  will  determine  whether  each 
cisterna is discrete or part of an interconnected whole. 
The presence of each enzyme in two adjacent cisternae 
might be relevant to cisternal stacking. Golgi residents are 
retained in their appropriate cisternae by retention signals in 
The Journal of Cell Biology, Volume 120,  1993  10 Figure 7. Distribution  of GaIT and mycNAGT I by confocal microscopy. Cells were fixed, permeabilized, and labeled with anti GaIT and 
9El0 antibodies followed by appropriate  second antibodies to reveal GaIT (green) and mycNAGT I (red). Z sections were taken every 
0.5/zm, from top to bottom, parallel to the coverslip, and nine were needed to encompass the whole cell. Sections 4 (A-C), 5 (D-F), 
6 (G-I), and 7 (J-L) are shown with the cell nucleus in the middle. The unmerged pictures are shown in the two columns on the left, 
the merged picture in the column on the right.  The indicated structures are discussed  in Results. Bar, 7/zm. 
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1991; Munro, 1991; Nilsson et al., 1991; Aoki et al., 1992; 
Colley et al., 1992; Russo et al., 1992; Teasdale et al., 1992; 
Wong et al.,  1992).  The flanking regions and cytoplasmic 
taft may play an accessory role (Munro, 1991; Nilsson et al., 
1991). The retention mechanism is unclear but an attractive 
possibility is that the residents of each cisterna form hetero- 
oligomers so large that they cannot enter budding vesicles 
and so are retained. If such oligomers were present in adja- 
cent cisternae, but only on one face such that they could in- 
teract across the intercisternal gap, then this would provide 
a stacking mechanism and explain why they are present in 
two cisteruae. A  linking protein would be needed to join 
the short cytoplasmic tails because the intercisternal space 
is '~I00 ~  in width. Such a mechanism could accommodate 
any number of cisternae and provide a template for reassem- 
bling the Golgi both at the end of mitosis (Lucocq et al., 
1989) or after treatment with drugs such as brefeldin A (for 
review see Klausner, 1992).  Unfortunately, it has not been 
possible to obtain evidence for such a  distribution of en- 
zymes within the cisternae. They are too narrow, relative to 
the size of the antibodies and gold conjugates, to determine 
which side the labeling is on and all efforts to enlarge the 
cisternae selectively have, so far, failed. 
Although most of each enzyme is present in two adjacent 
cisternae there is also some in the cisternae on either side. 
Though statistically insignificant (with one exception) at the 
p  =  0.05 level, the levels are many-fold higher than back- 
ground and they tail off in the cisternae furthest from the la- 
beled two. They could indicate a recycling pathway which 
makes up for any deficiencies in the Golgi retention mecha- 
nism. NAGT I, leaving the trans-cisterna, would end up in 
the TGN and be returned to an earlier part of the stack, per- 
haps the cis-cisterna. This retrograde pathway might be simi- 
lar to one of those already described (for reviews see Pel- 
ham, 1989; Klausner, 1992) and would imply the presence 
of a retrieval signal on Golgi enzymes as has been shown for 
both soluble and membrane proteins of the ER. The rate of 
recycling should ensure that each molecule of NAGT I passes 
through the TGN at least once within its lifetime so one 
would expect to see evidence of such passage from examina- 
tion of bound oligosaccharides. The absence of N-linked 
oligosaccharides from NAGT I  precludes analysis of this 
protein but mannosidase II, which should codistribute with 
NAGT I, exhibits trans-Golgi modifications such as sulpha- 
tion of N-linked oligosaccharides (Moremen and Touster, 
1985),  consistent with a recycling pathway. 
Stable cell lines such as that described here should solve 
the problem of localizing Golgi enzymes. Available antibod- 
ies  to  resident  Golgi  proteins  are  either  unsuitable  for 
immuno-EM or have a  very restricted species specificity. 
This paper,  in fact, represents the first double labeling of 
Golgi enzymes originally thought to be in different  cisternae. 
Earlier comparisons had to rely on those features of the 
Golgi that could be measured in different cell types such as 
cisternal number, morphology, and cytochemical reactivity. 
Unfortunately, these criteria were inadequate as evidenced 
by the present work though the generality of  our observations 
must await the production of other stable lines expressing 
mycNAGT I. There are several tags, other than myc, which 
work by immuno-electron microscopy so as more and more 
Golgi enzymes are cloned and sequenced, they can be tagged 
and expressed, either stably or transiently, in the mycNAGT I 
line. Double labeling v~uld then allow precise localization 
relative to mycNAGT I, with no need to consider morphol- 
ogy beyond the ability to determine the physical boundary 
of the cisterna being measured.  This approach is not re- 
stricted to cell type and should, in time, allow a complete 
map of the Golgi enzymes to be built up. 
A panel of stable cell lines expressing different, tagged 
Golgi enzymes would also be useful for assigning locations 
to other proteins. There are many antibodies which appear 
to stain the Golgi region but do not work by immuno-EM, 
so  that the  precise  location cannot be  determined.  Our 
results using co~  microscopy show that different parts 
of the Golf# apparatus can be distinguished. The resolution 
of  this technique must be of  the order of  0.05 ~,m, comprising 
the width of the cisterna (~,,0.04 tzm) and the intercisternal 
space (~0.01 ~,m), which is slightly better than the theoreti- 
cal resolution of 0.1/zm. It should not only be possible to 
assign proteins to the Golgi apparatus but even to particular 
parts of it. This would remove much of the present uncer- 
tainty and provide a firmer foundation upon which to test 
models of Golgi function. 
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